Quality of Life and Performance Status From a Substudy Conducted Within a Prospective Phase 3 Randomized Trial of Concurrent Accelerated Radiation Plus Cisplatin With or Without Cetuximab for Locally Advanced Head and Neck Carcinoma: NRG Oncology Ra

scientific article

Quality of Life and Performance Status From a Substudy Conducted Within a Prospective Phase 3 Randomized Trial of Concurrent Accelerated Radiation Plus Cisplatin With or Without Cetuximab for Locally Advanced Head and Neck Carcinoma: NRG Oncology Ra is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.IJROBP.2016.08.003
P8608Fatcat IDrelease_iuknusq47rfx5nfpz3avjssegi
P932PMC publication ID5303682
P698PubMed publication ID27727066

P50authorDavid I. RosenthalQ57015055
Quynh-Thu LeQ89881427
Adam S GardenQ90650674
Randal WeberQ94950283
James E GalvinQ96836608
Adel K El-NaggarQ114738475
Marcie ListQ114738535
Phuc Felix Nguyen-TânQ114738536
Rita S AxelrodQ114738537
Andy M TrottiQ114738540
P2093author name stringDavid Schwartz
Qiang Zhang
Christopher U Jones
Anurag Singh
George Shenouda
Deborah Bruner
James A Bonner
Minh Tam Truong
Craig Silverman
Eric Sherman
Karen Godette
Chance Matthiesen
André Konski
P2860cites workHuman papillomavirus and survival of patients with oropharyngeal cancer.Q27851567
Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522.Q34171999
The Functional Assessment of Cancer Therapy scale: development and validation of the general measureQ34361336
US valuation of the EQ-5D health states: development and testing of the D1 valuation model.Q34396720
Estimation of minimally important differences in EQ-5D utility and VAS scores in cancerQ36471118
Toxicities affecting quality of life after chemo-IMRT of oropharyngeal cancer: prospective study of patient-reported, observer-rated, and objective outcomesQ36565969
The development of a Functional Assessment of Cancer Therapy (FACT) questionnaire to assess dermatologic symptoms associated with epidermal growth factor receptor inhibitors (FACT-EGFRI-18).Q38057970
Quality of Life and Performance Status From a Substudy Conducted Within a Prospective Phase 3 Randomized Trial of Concurrent Standard Radiation Versus Accelerated Radiation Plus Cisplatin for Locally Advanced Head and Neck Carcinoma: NRG Oncology RTQ39302927
Effect of p16 Status on the Quality-of-Life Experience During Chemoradiation for Locally Advanced Oropharyngeal Cancer: A Substudy of Randomized Trial Trans-Tasman Radiation Oncology Group (TROG) 02.02 (HeadSTART).Q39746367
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patientsQ43681440
The M. D. Anderson symptom inventory-head and neck module, a patient-reported outcome instrument, accurately predicts the severity of radiation-induced mucositisQ46732613
The Performance Status Scale for Head and Neck Cancer Patients and the Functional Assessment of Cancer Therapy-Head and Neck Scale. A study of utility and validity.Q51113959
A performance status scale for head and neck cancer patients.Q52866767
Quality of life in head and neck cancer patients after treatment with high-dose radiotherapy alone or in combination with cetuximab.Q53190270
Quality of life and performance in advanced head and neck cancer patients on concomitant chemoradiotherapy: a prospective examination.Q53556812
Pretreatment quality of life predicts for locoregional control in head and neck cancer patients: a radiation therapy oncology group analysis.Q54141723
Interpreting clinically significant changes in patient-reported outcomesQ58876704
Performance and quality of life outcome in patients completing concomitant chemoradiotherapy protocols for head and neck cancerQ73518553
Pretreatment factors significantly influence quality of life in cancer patients: a Radiation Therapy Oncology Group (RTOG) analysisQ82969960
P433issue4
P407language of work or nameEnglishQ1860
P921main subjectcisplatinQ412415
cetuximabQ420296
quality of lifeQ13100823
head and neck carcinomaQ18554836
phase III clinical trialQ42824827
P304page(s)687-699
P577publication date2016-08-12
P1433published inInternational Journal of Radiation Oncology Biology PhysicsQ2296252
P1476titleQuality of Life and Performance Status From a Substudy Conducted Within a Prospective Phase 3 Randomized Trial of Concurrent Accelerated Radiation Plus Cisplatin With or Without Cetuximab for Locally Advanced Head and Neck Carcinoma: NRG Oncology Ra
P478volume97

Reverse relations

cites work (P2860)
Q39245984A systematic literature review of health state utility values in head and neck cancer.
Q54217162Associations among human papillomavirus, inflammation, and fatigue in patients with head and neck cancer.
Q104285299Conditional survival among patients with oropharyngeal cancer treated with radiation therapy and alive without recurrence 5 years after diagnosis
Q92180514Estimating health state utility from activities of daily living in the French National Hospital Discharge Database: a feasibility study with head and neck cancer
Q47437702General health-related quality of life scores from head and neck squamous cell carcinoma patients obtained throughout the first year following diagnosis predicted up to 10-year overall survival
Q46326125Patient-reported quality-of-life outcomes after de-escalated chemoradiation for human papillomavirus-positive oropharyngeal carcinoma: Findings from a phase 2 trial.
Q91665125Prognostic value of patient-reported outcomes from international randomised clinical trials on cancer: a systematic review
Q42288639Prospective observational study of carbon-ion radiotherapy for non-squamous cell carcinoma of the head and neck.
Q88399066Racial disparity in oncologic and quality-of-life outcomes in patients with locally advanced head and neck squamous cell carcinomas enrolled in a randomized phase 2 trial

Search more.